biosimilars News

Amgen Reports Stellar Q2 Performance with a 9% Revenue Surge to $9.2 Billion

Amgen Inc. reports a 9% revenue increase to $9.2 billion in Q2 2025, with net income and EPS soaring by 92%. The company also highlights strong first-half performance and reaffirms...

Biocon's Strategic Leap: Dominating Generics and Biosimilars for Global Growth

Biocon is focusing on new product launches in generics and biosimilars to fuel its expansion, leveraging the Viatris acquisition for an integrated biosimilars enterprise model. The...